Search
Menu
Home
HTB
2003
December
December 2003
Contents
Editorial
Volume 4 Number 10 December 2003
Conference reports
9th European AIDS Conference (EACS), 25-29 October 2003, Warsaw
Lower doses of d4T produce similar efficacy and reduced side effects
Switching from efavirenz to nevirapine to avoid CNS side effects
Interruption of treatment is safe for those who started too early
T20 is cost effective for UK purchasers
Intrauterine exposure to efavirenz
African patients and adherence in the UK
Five-year results of Kaletra-based therapy in treatment-naïve HIV patients
IL-2 effectively increases CD4 count in people with low CD4 nadir
Hepatitis coinfection: incidence in Europe and response to transplant
Rituximab plus CDE for HIV-related Non-Hodgkins Lymphoma (NHL)
Antiretrovirals
FTC (emtricitabine, Emtriva) approved in Europe
EMEA recommend approval for atazanavir for treatment experienced patients
Fosamprenavir (Lexiva) approved in US
US paediatric, adult and maternal-child guidelines updated
Treatment access
Access to treatment – some progress…
WHO approves combination pills
South African Competition Commission finds GSK and BI responsible for ‘excessive pricing’ and ‘abuse of market position’
Access to HIV treatment in Eastern Europe
Paediatric care
Dramatic decline in mortality, disease progression and hospital admissions in children with HIV infection in the UK and Ireland
New tool for assessing risks of disease progression and death based on age, CD4 percentage and viral load in HIV-infected children
Side effects
Increased risk of myocardial infarction associated with duration of protease inhibitor treatment
Weight, diabetes, metabolic complications
Polylactic acid (New-gill) repairs facial wasting and improves quality of life
Hepatitis coinfection
UK guidelines for treating coinfection with HIV and hepatitis B or C published online
Kidney and liver transplantation in HIV-infected patients: case presentations and review
London epidemic of sexually transmitted hepatitis C
Vaccines and microbicides
VaxGen AIDSVAX vaccine fails in Thailand
On the web
Conferences
Online medical lectures
Newsletters and reports
HIV and hepatitis coinfection
Other news
PDFs
Volume 4 Number 10 December 2003/January 2004 PDF
HTB RSS
Early access
CROI 2025: Jay Bhattacharya is proposed to head the US NIH which would further wreck global science
7 March 2025
All early access reports
Current issues
March 2025
February 2025
January 2025
Back issues
Special report
Global update: 90-day review ended early and cancelled 10,000 grants, millions of people will suffer
1 March 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate